Rapid responses are electronic comments to the editor. They enable our users to debate issues raised in articles published on bmj.com. A rapid response is first posted online. If you need the URL (web address) of an individual response, simply click on the response headline and copy the URL from the browser window. A proportion of responses will, after editing, be published online and in the print journal as letters, which are indexed in PubMed. Rapid responses are not indexed in PubMed and they are not journal articles. The BMJ reserves the right to remove responses which are being wilfully misrepresented as published articles.
Andrew Prayle and colleagues at the University of Nottingham,1. who reported on the basis of publicly available information that only 22% of the trials that should have reported their results on the ClinicalTrials.gov website had actually done so, are to be commended in addressing the shoddy public accountability of the FDA and NIH. These organizations owe the US Congress and the American people better accounting of reporting on the ClinicalTrials.gov website. The categories of studies on which the FDA bases its disagreement with Prayle and colleagues are precisely those which should be enumerated along with the rest in an annual compliance report. One would hope that US Congressman Henry Waxman will demand such an accounting in the future.
No competing interests
08 May 2012
John H Noble, Jr
Emeritus Professor, SUNY/Buffalo
Alliance for Human Research Protection, NY, NY, USA